REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MORNING BID-Between stimulus euphoria and virus dejection

Fri, 06th Mar 2020 09:15

A look at the day ahead from Karin Strohecker, chief
correspondent, emerging markets. The views expressed are her
own.
A glum end to another difficult week. We've seen wild swings in
major equity indexes, U.S. Treasury yields collapsing below 1%
and investors torn between euphoria over monetary and fiscal
stimulus measures on one hand and fears over the coronavirus on
the other. Fear has the upper hand today, with equities falling
and the dollar weakening against the yen and the euro.

World stocks are actually up almost 2% so far this week,
buoyed by the Federal Reserve's emergency rate cut on Tuesday
and rebounding from last week's $6 trillion selloff. But those
weekly gains could get wiped out by the end of the day after
steep declines in Asia. Japanese stocks fell nearly 3% to a six-
month low; Hong Kong and South Korea nearly matched that
decline. European markets followed; the London, Paris, Milan and
Frankfurt exchanges all dropped 1.5% to 2% in early trade. U.S.
futures point to a 1% fall when Wall Street opens.

Coronavirus also overshadows much of the data coming out --
U.S. non-farm payroll numbers are expected to show a 175,000
increase in jobs after a 225,000 rise in January.

In corporate news, Airbus shares tumbled 3% as it
got zero orders in February. EssilorLuxottica also
tumbled 3% at open after the company said it expects is
first-half revenues to be slower.

Infineon fell 0.3% after Bloomberg reported that
Washington recommended Trump block the German chipmaker's
proposed $10 billion deal to buy Cypress Semiconductor.
AstraZeneca fell 0.3% after a combination treatment for
a form of bladder cancer failed to meet its main goal.

On fixed-income markets, yields of safe-haven debt continue
to tumble, with U.S. Treasuries seeing the biggest shakeout.
U.S. 10-year yields are down 10 bps, below 1%. Two-year U.S.
Treasury yields have dropped almost 85 bps in the past two weeks
– their biggest two-week drop since 1987. Ten-year UST yields
are headed for their biggest two-week drop since the financial
crisis in 2008.

Germany's benchmark 10-year Bund yield is within striking
distance of record lows reached six months ago.

Markets are pricing in further rate cuts after the Fed's 50
bps emergency move Tuesday. Another 40 bps of cuts is priced for
March, with about a 60% chance of a more aggressive 50 bps cut.
For ECB, the market expects a 10 bps rate cut at next Thursday's
meeting and a total of two rates cuts by year end.

The slide in U.S. Treasury yields further eroded the
dollar's interest rate advantage. The euro rose to a
near-three-year high against the U.S. currency, which sank to
its lowest in more than five months against the yen, which was
also benefiting from some safe-haven flows.

Emerging-market stocks slipped for the first time in five
trading sessions, falling 1.8% on Friday. Chinese stocks slipped
1.6% but still managed their best week in a year as investors
welcomed Beijing's attempts to control the virus.

Emerging-market currencies were generally weaker, but the
dollar's weakness put China's yuan on track for a second
straight weekly gain. The South Korean won was set for its best
week since 2017, thanks also to a fiscal stimulus package

In Turkey, a ceasefire deal for Syria's Idlib region went
into effect but hasn't so far helped the lira.

Lebanon's government meets on Saturday to take a decision on
its $1.2 billion Eurobond maturing March 9. The state prosecutor
suspended an order freezing assets of 20 banks, warning it would
plunge the country's financial sector into chaos.

After a sweeping government reshuffle this week, Ukraine's
new prime minister, Denys Shmygal, said the government would
continue "constructive" work with the International Monetary
Fund. Argentina's central bank lowered its benchmark interest
rate to 38% from 40% on Thursday, the eighth cut since the
middle of December.
DATA & EVENTS
German industrial orders
UK Halifax house prices
Russia Feb inflation
Non-farm payrolls for Feb/average earnings
US trade balance Jan
US wholesale inventories, consumer credit Jan
(Editing by Larry King)

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.